Inventor
BEARD CLAYTON
US5 patents
Patents
5 patentsUS11053484B2Jul 6, 2021
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
PREC BIOSCIENCES INC5 citations82
US11278632B2Mar 22, 2022
Engineered nucleases useful for treatment of hemophilia A
PREC BIOSCIENCES INC0 citations61
US12448613B2Oct 21, 2025
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
PREC BIOSCIENCES INC0 citations60
US12595470B2Apr 7, 2026
Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A
PREC BIOSCIENCES INC0 citations57
US10745665B2Aug 18, 2020
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
PREC BIOSCIENCES INC0 citations35